TY - JOUR AU - H. E. Wainman AU - S. Gallard AU - M. J. Ridd AU - J. R. Ingram A1 - AB - BACKGROUND: Hidradenitis suppurativa (HS) is a painful, chronic, inflammatory skin condition affecting the skin folds. It is frequently misdiagnosed, leading to delays in care and the progression of the disease to permanent scarring. AIM: To understand the level of knowledge and confidence of HCPs in primary care managing patients with HS. To establish their ability to recognise the early signs of HS, awareness of associated comorbidities, and recognition of treatment options available in primary care. DESIGN & SETTING: A survey was distributed to HCPs working in primary care METHOD: The survey was disseminated via weekly GP bulletins distributed by local integrated care boards, the primary care dermatology society mailing lists and at professional events. RESULTS: Of 187 respondents, most (93%) did not have a specialist role in dermatology or a postgraduate qualification in dermatology (69%), 36 (20%) were not doctors, and there was a good geographical spread over the UK. Of the respondents, 74% felt confident diagnosing HS, but only 39% were confident in managing the pain associated with the disease. Perceived confidence did not correlate with understanding the importance of early referral to secondary care where multiple skin sites were affected. CONCLUSION: Further education in diagnosing and managing HS in primary care is needed. Future research could focus on developing a tool to support the diagnosis of HS in primary care and a clear, primary care-focused management guideline for identified patients. AD - Bristol Dermatology Centre,Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom hannah.wainman@bristol.ac.uk.; Centre for Applied Excellence in Skin & Allergy Research, University of Bristol, Bristol, United Kingdom.; Royal Liverpool University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.; Division of Infection & Immunity, Cardiff University, Cardiff, United Kingdom. AN - 40550630 BT - BJGP Open C5 - Healthcare Disparities DA - Jun 23 DO - 10.3399/bjgpo.2025.0060 DP - NLM ET - 20250623 JF - BJGP Open LA - eng N2 - BACKGROUND: Hidradenitis suppurativa (HS) is a painful, chronic, inflammatory skin condition affecting the skin folds. It is frequently misdiagnosed, leading to delays in care and the progression of the disease to permanent scarring. AIM: To understand the level of knowledge and confidence of HCPs in primary care managing patients with HS. To establish their ability to recognise the early signs of HS, awareness of associated comorbidities, and recognition of treatment options available in primary care. DESIGN & SETTING: A survey was distributed to HCPs working in primary care METHOD: The survey was disseminated via weekly GP bulletins distributed by local integrated care boards, the primary care dermatology society mailing lists and at professional events. RESULTS: Of 187 respondents, most (93%) did not have a specialist role in dermatology or a postgraduate qualification in dermatology (69%), 36 (20%) were not doctors, and there was a good geographical spread over the UK. Of the respondents, 74% felt confident diagnosing HS, but only 39% were confident in managing the pain associated with the disease. Perceived confidence did not correlate with understanding the importance of early referral to secondary care where multiple skin sites were affected. CONCLUSION: Further education in diagnosing and managing HS in primary care is needed. Future research could focus on developing a tool to support the diagnosis of HS in primary care and a clear, primary care-focused management guideline for identified patients. PY - 2025 SN - 2398-3795 ST - Management of hidradenitis suppurativa in UK primary care: cross-sectional survey T1 - Management of hidradenitis suppurativa in UK primary care: cross-sectional survey T2 - BJGP Open TI - Management of hidradenitis suppurativa in UK primary care: cross-sectional survey U1 - Healthcare Disparities U3 - 10.3399/bjgpo.2025.0060 VO - 2398-3795 Y1 - 2025 ER -